ROC curves were generated for serum TGFβ1 to evaluate its ability to distinguish PDTC from benign pancreas disease, lymph node metastasis from non-lymph node metastasis and stages I and II from stages III and IV. This evidence concerns the gene TGFB1 and metastatic malignant neoplasm in the lymph nodes.